BridgeMD

Sign in

Rhinitis clinical trials

Explore recruiting rhinitis clinical trials.

Recruiting rhinitis studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rhinitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial to evaluate efficacy and safety of immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae and Lepidoglyphus destructor.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial to evaluate efficacy and safety of immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae and Blomia tropicalis

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, multicenter, randomized, double-blind, placebo-controlled, efficacy and safety clinical trial with subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma sensitized to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial of efficacy and safety with Dermatophagoides pteronyssinus and Dermatophagoides farinae mannan-conjugated allergoids in patients with rhinitis/rhinoconjunctivitis, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae _MM09-SIT-069

Portugal, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Clinical trial to evaluate the safety, tolerability and effectiveness of a medicinal nasal insert in the treatment of chronic hay fever.- Inspicare

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Prospective, multicentre, randomized, double-blind, placebo-controlled, clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma sensitized to grasses and cupressaceae

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Rhinitis trials by city

Rhinitis in Toronto Rhinitis in Vancouver Rhinitis in Montreal Rhinitis in Calgary Rhinitis in Edmonton Rhinitis in Ottawa Rhinitis in Winnipeg Rhinitis in Quebec City Rhinitis in Hamilton Rhinitis in Kitchener Rhinitis in London Rhinitis in Halifax Rhinitis in New York Rhinitis in Los Angeles Rhinitis in Chicago Rhinitis in Houston